Seroprevalence of human herpesvirus 8 and its impact on the hemoglobin level in patients of end stage of renal diseases

Qiwen Fang, Xiaoyi Wang, Zhenqiu Liu, Ming Zhu, Min Ding, Veenu Minhas, Charles Wood, Tiejun Zhang

Research output: Contribution to journalArticle

Abstract

The incidence of Kaposi's sarcoma (KS) is increasing among renal transplant recipients. Patients with end-stage renal disease (ESRD) are immunocompromised and are candidates for renal transplantation, but HHV8 seroprevalence in ESRD patients has not been well documented. A cross-sectional study of 286 ESRD patients and 281 matched subjects without kidney disease was conducted at the First People's Hospital of Huzhou, Zhejiang province to explore the epidemiologic features of HHV8 among ESRD patients in China. Blood samples were collected and HHV8 antibodies and serologic indices were measured. The seroprevalence of HHV8 was 15.3% for ESRD patients and 8.9% for the comparison group. A significant difference in the geometric mean titer (GMT) of the HHV8 antibodies was detected between ESRD patients and the comparison group (617.1 vs 291.7; P=0.042). The average level of hemoglobin was 11.56±1.78g/dL for the ESRD group and 13.73±1.42g/dL for the comparison group, (P>0.05). Multiple linear regression revealed a negative association between HHV8 infection and plasma hemoglobin concentration (β=-0.682, P=0.036). We found a higher HHV8 prevalence and a higher level of HHV8 antibody GMT in ESRD patients than the comparison group, which indicate a high risk of posttransplantation KS.

Original languageEnglish (US)
JournalJournal of Medical Virology
DOIs
StateAccepted/In press - 2017

Fingerprint

Human Herpesvirus 8
Seroepidemiologic Studies
Chronic Kidney Failure
Hemoglobins
Kaposi's Sarcoma
Antibodies
Kidney Diseases
Kidney Transplantation
Linear Models
China
Cross-Sectional Studies
Kidney
Incidence

Keywords

  • End-stage renal disease
  • Human herpesvirus 8
  • Prevalence

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Seroprevalence of human herpesvirus 8 and its impact on the hemoglobin level in patients of end stage of renal diseases. / Fang, Qiwen; Wang, Xiaoyi; Liu, Zhenqiu; Zhu, Ming; Ding, Min; Minhas, Veenu; Wood, Charles; Zhang, Tiejun.

In: Journal of Medical Virology, 2017.

Research output: Contribution to journalArticle

Fang, Qiwen ; Wang, Xiaoyi ; Liu, Zhenqiu ; Zhu, Ming ; Ding, Min ; Minhas, Veenu ; Wood, Charles ; Zhang, Tiejun. / Seroprevalence of human herpesvirus 8 and its impact on the hemoglobin level in patients of end stage of renal diseases. In: Journal of Medical Virology. 2017.
@article{ffe0ff79acc94e65bb30e5d8d7e14f77,
title = "Seroprevalence of human herpesvirus 8 and its impact on the hemoglobin level in patients of end stage of renal diseases",
abstract = "The incidence of Kaposi's sarcoma (KS) is increasing among renal transplant recipients. Patients with end-stage renal disease (ESRD) are immunocompromised and are candidates for renal transplantation, but HHV8 seroprevalence in ESRD patients has not been well documented. A cross-sectional study of 286 ESRD patients and 281 matched subjects without kidney disease was conducted at the First People's Hospital of Huzhou, Zhejiang province to explore the epidemiologic features of HHV8 among ESRD patients in China. Blood samples were collected and HHV8 antibodies and serologic indices were measured. The seroprevalence of HHV8 was 15.3{\%} for ESRD patients and 8.9{\%} for the comparison group. A significant difference in the geometric mean titer (GMT) of the HHV8 antibodies was detected between ESRD patients and the comparison group (617.1 vs 291.7; P=0.042). The average level of hemoglobin was 11.56±1.78g/dL for the ESRD group and 13.73±1.42g/dL for the comparison group, (P>0.05). Multiple linear regression revealed a negative association between HHV8 infection and plasma hemoglobin concentration (β=-0.682, P=0.036). We found a higher HHV8 prevalence and a higher level of HHV8 antibody GMT in ESRD patients than the comparison group, which indicate a high risk of posttransplantation KS.",
keywords = "End-stage renal disease, Human herpesvirus 8, Prevalence",
author = "Qiwen Fang and Xiaoyi Wang and Zhenqiu Liu and Ming Zhu and Min Ding and Veenu Minhas and Charles Wood and Tiejun Zhang",
year = "2017",
doi = "10.1002/jmv.24937",
language = "English (US)",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Seroprevalence of human herpesvirus 8 and its impact on the hemoglobin level in patients of end stage of renal diseases

AU - Fang, Qiwen

AU - Wang, Xiaoyi

AU - Liu, Zhenqiu

AU - Zhu, Ming

AU - Ding, Min

AU - Minhas, Veenu

AU - Wood, Charles

AU - Zhang, Tiejun

PY - 2017

Y1 - 2017

N2 - The incidence of Kaposi's sarcoma (KS) is increasing among renal transplant recipients. Patients with end-stage renal disease (ESRD) are immunocompromised and are candidates for renal transplantation, but HHV8 seroprevalence in ESRD patients has not been well documented. A cross-sectional study of 286 ESRD patients and 281 matched subjects without kidney disease was conducted at the First People's Hospital of Huzhou, Zhejiang province to explore the epidemiologic features of HHV8 among ESRD patients in China. Blood samples were collected and HHV8 antibodies and serologic indices were measured. The seroprevalence of HHV8 was 15.3% for ESRD patients and 8.9% for the comparison group. A significant difference in the geometric mean titer (GMT) of the HHV8 antibodies was detected between ESRD patients and the comparison group (617.1 vs 291.7; P=0.042). The average level of hemoglobin was 11.56±1.78g/dL for the ESRD group and 13.73±1.42g/dL for the comparison group, (P>0.05). Multiple linear regression revealed a negative association between HHV8 infection and plasma hemoglobin concentration (β=-0.682, P=0.036). We found a higher HHV8 prevalence and a higher level of HHV8 antibody GMT in ESRD patients than the comparison group, which indicate a high risk of posttransplantation KS.

AB - The incidence of Kaposi's sarcoma (KS) is increasing among renal transplant recipients. Patients with end-stage renal disease (ESRD) are immunocompromised and are candidates for renal transplantation, but HHV8 seroprevalence in ESRD patients has not been well documented. A cross-sectional study of 286 ESRD patients and 281 matched subjects without kidney disease was conducted at the First People's Hospital of Huzhou, Zhejiang province to explore the epidemiologic features of HHV8 among ESRD patients in China. Blood samples were collected and HHV8 antibodies and serologic indices were measured. The seroprevalence of HHV8 was 15.3% for ESRD patients and 8.9% for the comparison group. A significant difference in the geometric mean titer (GMT) of the HHV8 antibodies was detected between ESRD patients and the comparison group (617.1 vs 291.7; P=0.042). The average level of hemoglobin was 11.56±1.78g/dL for the ESRD group and 13.73±1.42g/dL for the comparison group, (P>0.05). Multiple linear regression revealed a negative association between HHV8 infection and plasma hemoglobin concentration (β=-0.682, P=0.036). We found a higher HHV8 prevalence and a higher level of HHV8 antibody GMT in ESRD patients than the comparison group, which indicate a high risk of posttransplantation KS.

KW - End-stage renal disease

KW - Human herpesvirus 8

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=85030307981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030307981&partnerID=8YFLogxK

U2 - 10.1002/jmv.24937

DO - 10.1002/jmv.24937

M3 - Article

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

ER -